Blockade of Insulin Receptor Substrate-1 Inhibits Corneal Lymphangiogenesis

Abstract

Blockade of IRS-1 inhibits not only hemangiogenesis but also lymphangiogenesis. To the authors' knowledge, this is the first evidence that IRS-1 is involved in the molecular pathway leading to lymphangiogenesis.